Biomatter

General Information

Company Name

Biomatter

Founded Year

2018

Location (Offices)

Lithuania +1

Founders / Decision Makers

Number of Employees

Industries

Biopharma, Biotechnology, Life Sciences +1

Funding Stage

Seed

Social Media

Biomatter - Company Profile

Biomatter is a synthetic biology startup with a focus on creating new proteins for health and sustainable manufacturing. The company's Intelligent Architecture™ platform aims to revolutionize protein design and development by addressing current engineering limitations. Founded in 2018 and based in Lithuania, Biomatter recently received a significant boost with a €6.50M investment in a Seed Round on 05 August 2024. The investors in this round include Practica Capital, UVC Partners, Metaplanet Holdings, and Inventure. With a focus on the biopharma, biotechnology, life sciences, and pharmaceutical industries, Biomatter is well-positioned to make a lasting impact in the field of synthetic biology.

Taxonomy: synthetic biology, biocatalysis, enzyme design, enzyme optimization, enzyme discovery, enzyme engineering, biomanufacturing, protein design, protein engineering, sustainable manufacturing, biomatter, api manufacturing, chemical manufacturing, life sciences